Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma
Linvoseltamab 与真实世界中国际骨髓瘤工作组标准治疗方案在三线抗肿瘤治疗后复发/难治性多发性骨髓瘤中的比较
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-026-01466-2
Kumar, Shaji; Jagannath, Sundar; Weisel, Katja C; Rosiñol, Laura; Leleu, Xavier; Dimopoulos, Meletios-Athanasios; Kastritis, Efstathios; Siegel, David S; Monge, Jorge; Du, Juan; de la Rubia, Javier; Asensi Cantó, Pedro; Lee, Jae Hoon; Mateos, María-Victoria; Puertas, Borja; Gozzetti, Alessandro; Dytfeld, Dominik; Ocio, Enrique M; Blade, Joan; Ozaki, Shuji; Beksac, Meral; Escalante, Fernando; Nagaraj, Madhu; Hassan, Rafla; Bonar, Nicolle; Spin, Paul; Shokoohi, Mostafa; Siddiqui, Muhaimen; Wang, Di; Hou, Kevin; West, Michael E D; Hampp, Christian; Green, Jeannette; Humblet, Olivier; Breskin, Alexander; Harnett, James; Ge, Wenzhen; Sobel, Rachel E; Jalbert, Jessica J; Kroog, Glenn S; Rodriguez Lorenc, Karen; Ma, Qiufei; Durie, Brian G M
